West Virginia University
Yon Rojanasakul, Ph.D., is a Professor in the Department of Pharmaceutical Sciences at West Virginia University. Dr. Rojanasakul’s research focuses on understanding the cellular and molecular mechanisms of cancer and fibroproliferative disorders. His research has led to the discovery of key molecular targets and signaling pathways involved in cancer cell death and chemoresistance. The overall goal of his research is to develop more effective strategies for the treatment and diagnosis of cancer and fibrosis. Another key area of Rojanasakul’s research involves nanotechnology with an emphasis on the long-term health effects of engineered nanoparticles. His research develops exposure models and assay methods for nanosafety evaluation, identifies key properties of nanomaterials influencing their bioactivities, and elucidates the cellular and molecular mechanisms of pathogenesis. Dr. Rojanasakul is Principal Investigator of several projects funded by the National Institutes of Health and the National Science Foundation. He is Robert C. Byrd Professor and Benedum Distinguished Scholar at the West Virginia University. He is also a Fellow of the American Association of Pharmaceutical Scientists and Program Leader of the WVU Cancer Center.
Carcinogenesis and Cancer Treatment Nanosafety and Nanomedicine Free Radical Biology Molecular Pharmacology